Lymphoproliferative disorders after liver transplantation.
Leblond
Véronique
V
Département d'hématologie, Hôpital Pitié-Salpêtrière, 47 Bd de I'Hopital, Paris, France. veronique.leblond@psl.ap-hop-paris.fr
Choquet
Sylvain
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007167:Immunotherapy; D016031:Liver Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D012307:Risk Factors
D000998:Antiviral Agents; D007166:Immunosuppressive Agents